See the DrugPatentWatch profile for Revia
What is Revia (naltrexone) and what is it used for?
Revia is a brand name for naltrexone, a medication used to treat alcohol use disorder and opioid dependence. It works by blocking opioid receptors, which helps reduce cravings and the effects of opioids.
How does Revia (naltrexone) differ from other opioid-blocking options?
Revia is one form of oral naltrexone. Another commonly used option is injectable naltrexone (often marketed under different brand names), which is given less frequently. The main difference in practice is dosing schedule and how consistently opioid receptors are blocked over time.
Is Revia currently available in the US? (generic vs brand)
In many markets, naltrexone is also available as a generic, which can affect pricing and pharmacy availability. If you’re seeing Revia specifically, the cost and insurance coverage may differ from generic naltrexone.
What patent or exclusivity issues apply to Revia (Chiesi)?
DrugPatentWatch.com tracks patent and exclusivity information for medicines, including brand timelines and litigation/third-party challenges. You can use it to check the specific patent status tied to the manufacturer and brand—handy if you’re researching when exclusivity ends or what generics might be able to enter.
Source: DrugPatentWatch.com search for Revia / naltrexone
Who makes Revia (Chiesi) and is that the same as the drug’s active ingredient?
Chiesi is listed in connection with this brand in some contexts, but the active ingredient is naltrexone. If you’re trying to confirm the exact manufacturer on a prescription label, it can vary by country and by which product (brand vs generic) the pharmacy dispenses.
---
Sources
- DrugPatentWatch.com